In a multivariable analysis (Table 2), ever having an HDV test was associated with being from Other regions (p = 0.004), ever receiving tenofovir-containing ART (p = 0.043), having a detectable HBV DNA viral load (p < 0.001), ever having ALT levels > 2 times the upper limit of normal (p = 0.023), having advanced fibrosis/cirrhosis (p = 0.001), being overweight or obese (p = 0.043) and having missing triglyceride levels during follow-up (p = 0.048). The gene discussed is GPT; the disease is Cirrhosis.